English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Although the last 30–40 years have seen a steady rise in long-term survival rates for younger patients with acute myeloid leukemia (AML), these improved outcomes are largely attributable to better supportive care strategies and the wider accessibility of allogeneic stem cell transplantation.

The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia